Alzamend Neuro has partnered with Massachusetts General Hospital to conduct a pioneering Phase II clinical trial of its AL001 treatment for PTSD, led by Dr. Ovidiu Andronesi.
Tag: ALZN
Bitcoin(BTC)$76,139.66-0.23%
Ethereum(ETH)$3,025.793.33%
Tether USDt(USDT)$1.00-0.02%
Solana(SOL)$197.14-1.70%
BNB(BNB)$618.733.71%
USDC(USDC)$1.000.02%
XRP(XRP)$0.55-1.22%
Dogecoin(DOGE)$0.2048823.65%
Cardano(ADA)$0.436885-4.26%
TRON(TRX)$0.160326-0.75%